About Dr. Douglas Berger Psychiatrist Tokyo

Dr. Douglas Berger, M.D., Ph.D., Meguro Counseling Center Director

Douglas Berger, M.D., Ph.D., is the Director of the Tokyo Meguro Counseling Center.  Fully bilingual in English and Japanese, he is an American board certified psychiatrist. Dr. Douglas Berger is a graduate of New York Medical College where he also completed a 4-year residency program in psychiatry. Dr. Berger’s Japanese qualifications include a Ph.D. from the University of Tokyo School of Medicine received for psychiatric research done while at the Tokyo University Department of Psychosomatic Medicine. He also completed a fellowship in Psychosomatic Medicine at the Albert Einstein College of Medicine. Now living in Tokyo, Douglas Berger has served on the Faculty of the Albert Einstein College of Medicine Department of Psychiatry in New York as an Assistant Professor of Psychiatry and licensed practicing U.S. physician.

Credential Verifications

Dr. Berger’s medical degree is from the United States, he is well-versed in the use of psychiatric medication and can guide the use of psychiatric medications integrated with psychotherapy through the physicians affiliated with his counseling practice (he does not directly practice medical care in Japan). Further information on Dr. Berger can be seen on his personal home page or the web site of the Meguro Counseling Center.

Publications by Dr. Douglas Berger, psychiatrist in Tokyo

Berger D: DOUBLE-BLINDING AND BIAS IN MEDICATION AND COGNITIVE-BEHAVIORAL THERAPY TRIALS FOR MAJOR DEPRESSIVE DISORDER, F1000Research 2016, 4:638 (doi: 10.12688/f1000research.6953.2). U.S. National Library of Medicine version.

Berger D: DOUBLE BLINDING REQUIREMENT FOR VALIDITY CLAIMS IN COGNITIVE-BEHAVIORAL THERAPY INTERVENTION TRIALS FOR MAJOR DEPRESSIVE DISORDER. Analysis of Hollon S, et al., Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial, F1000Research 2015, 4:639 (doi: 10.12688/f1000research.6954.1). U.S. National Library of Medicine version.

Articles by Douglas Berger, M.D., Ph.D. for Tokyo Families magazine.

Dr. Berger came to Japan as a medical exchange student and psychiatric researcher at the Tokai University School of Medicine on a research fellowship from the Matsumae International Foundation. He later returned to Japan to do further psychiatric research at the Tokyo University Department of Psychosomatic Medicine and the Tokyo Institute of Psychiatry. Dr. Berger speaks native-level Japanese and regularly conducts psychotherapy for mixed-cultural couples as well as the local Japanese community. This page lists Dr. Berger’s research activity, and this page is an archive of community education articles for the Tokyo Families Magazine written by Dr. Berger. Dr. Berger also works extensively with children as Director of the Tokyo Child & Adolescent Counseling Service. Dr. Berger is a legal permanent resident of Japan.

Feel free to contact Douglas Berger psychiatrist Tokyo with our contact form or the Home Page of the Meguro Counseling Center.

https://t.co/CgpnuNNVNt: doesn’t mention the exclusion criteria for a personality disorder when the criteria can be explained by another psychiatric disorder. I.e., the diagnosis for BPD notes 7 traits that could easily be due to a mood disorder. Us: https://t.co/59gLBhYuMX

Brain changes have been reported with psychotherapy, but brain changes can be found in various activities: https://t.co/gQpNqj4Xqv found an increase in white matter underlying in a complex visuo-motor skill. Us: https://t.co/2rTavy34n4.

Dr. Steven King promotes efficacy of CBT for pain as best: https://t.co/QZzwfBWpnz, but there is no blind placebo-controlled study of CBT vs any other type of psychotherapy. Modesty in conclusion of efficacy is warranted. US: https://t.co/NExjz3T3Z3

Dr. Tasman starts on physicists questioning relativity vs quantum mechanics: https://t.co/Y0sjD2Tuos, leading to what is inner reality in psychotherapy? Dr. Tasman seems removed from understanding Einstein & Bohr's quantum discussions vs human reality. US: https://t.co/NExjz3T3Z3

Dr Moutier lists treatment modalities w/evidence for reducing suicide risk but surprisingly doesn't mention medication for agitation, anxiety, or sleep: https://t.co/5eSWg2sJOk. Neither CBT or DBT have ever had a double-blind placebo controlled study. US: https://t.co/We7OmvxoYF

Load More...

Until there is a reliable biological or genetic parameter that can validly discriminate BPD from other disorders, better modesty to admit that the diagnosis of a personality disorder, especially BPD, will still be far from a valid construct. Us: https://t.co/nCLCm8wkvq

Mindfulness has been found to alter regions of the brain associated with memory & awareness: https://t.co/ndcotXhNQF. But many activities can make brain changes, running, yoga, juggling, etc. there is no special effect to Mindfulness here. Us: https://t.co/CFTtRIymIU

The Psychiatric Times author of the ART (aka EMDR) infomercial, Dr. Wendi Waits, is also a " Master ART Therapist", a COI Psychiatric Times should note. EMDR as pseudoscience: https://t.co/PqEfLAZnq5, & on Quackwatch: https://t.co/i6MURVUfz1. Us: https://t.co/vCyo9ZNPlb.

Psychiatric Times is plugging EMDR as ART: https://t.co/IQcIwH2Zxd. Listed here as pseudoscience: https://t.co/PqEfLAZnq5, EMDR has a long history on Quackwatch: https://t.co/i6MURVUfz1. Us: https://t.co/vCyo9ZNPlb.

Borderline Personality will self-harm, ADHD persons get hyper: https://t.co/gSayzpsaks. There is really no way to differentiate these diagnoses & if a personality disorder is better explained by another disorder, the other disorder takes priority. US: https://t.co/GwwzyYyjaI

Load More...